Services
Neeman & Industry News
DCGI to implement e-Gov in its working The Drugs Controller General of India (DCGI) to have a single window facility for drug approval soon...
New Indian Regulatory Guidance by Central Drugs Standard Control Organization Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy - Central Drugs Standard Control Organization...
Indian Clinical Data Management market is expected to ramp up to $150 million MNCs are more than willing to outsource their needs to India because of it\'s technological innovation, creditable quality, operational flexibility, cost effectiveness, time-to-market and competitive advantage according to Koteshwar Govind, Deputy Manager,...
India: Attractive Market for Biopharmaceutical Companies Looking to Accelerate Their Clinical Trials The Clinical Research Market in India is growing at a very rapid rate according to anyone’s statistics…It is exploding according to all the hype. ...

Site Management » Regulatory Services


The Regulatory Affairs Department at Max Neeman is geared to provide the most effective regulatory assessment and strategy for timely submission and early approval.

The key advantages offered by Max Neeman\'s regulatory services include:
  • Advising the client on regulatory issues.
  • Preparation of the regulatory dossier as per the requirements of the regulatory agencies and sharing the regulatory dossier with the client for approval.
  •  Carrying out regulatory submissions on behalf of clients
    .
  •  Following up with the regulatory agencies, and carrying out query clarification and query resolution in consultation with the sponsors

  • Following with all concerned regulatory departments till approval is obtained